# FDA Inspection 808110 - Bloodworks - November 14, 2012

Source: https://www.keypedia.com/records/fda_inspections/bloodworks/97a3ee40-746d-4a96-a174-0f45e2cae1b1
Source feed: FDA_Inspections

> FDA Inspection 808110 for Bloodworks on November 14, 2012. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 808110
- Company Name: Bloodworks
- Inspection Date: 2012-11-14
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 953575 - 2016-01-05](https://www.keypedia.com/records/fda_inspections/bloodworks/e8b9ac59-b821-4faf-9ccc-f253d02e8b47)
- [FDA Inspection 866377 - 2014-02-19](https://www.keypedia.com/records/fda_inspections/bloodworks/5fa450ee-6614-4543-8898-e203c33c71ad)
- [FDA Inspection 759123 - 2011-12-06](https://www.keypedia.com/records/fda_inspections/bloodworks/a640f885-c8ce-44f0-a948-cfd82e0e0bef)

Company: https://www.keypedia.com/companies/bloodworks/13ade31d-ee36-47dd-85bd-c8be946a2a6d

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d